Talaris Therapeutics, Inc. (TALS) Earnings
|
Expand Research on TALS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +12.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -8.9% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/10/23 | Q323 | N/A | -$0.60 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/28/23 | Q223 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/21/23 | Q223 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/10/23 | Q223 | N/A | -$0.20 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/29/23 | Q123 | N/A | -$0.50 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/11/23 | Q123 | N/A | -$0.43 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/27/23 | Q422 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/20/23 | Q422 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A |
